CY2450B1 - Compositions and their uses. - Google Patents
Compositions and their uses.Info
- Publication number
- CY2450B1 CY2450B1 CY0400032A CY0400032A CY2450B1 CY 2450 B1 CY2450 B1 CY 2450B1 CY 0400032 A CY0400032 A CY 0400032A CY 0400032 A CY0400032 A CY 0400032A CY 2450 B1 CY2450 B1 CY 2450B1
- Authority
- CY
- Cyprus
- Prior art keywords
- useful
- compositions
- rejection
- xenografts
- epitopes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Transplantation (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9517758.0A GB9517758D0 (en) | 1995-08-31 | 1995-08-31 | Compositions and their uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY2450B1 true CY2450B1 (en) | 2005-06-03 |
Family
ID=10779983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY0400032A CY2450B1 (en) | 1995-08-31 | 2004-04-28 | Compositions and their uses. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0847280B1 (de) |
| JP (1) | JPH11511455A (de) |
| CN (1) | CN1198101A (de) |
| AT (1) | ATE228014T1 (de) |
| AU (1) | AU6829396A (de) |
| BR (1) | BR9609868A (de) |
| CA (1) | CA2229844A1 (de) |
| CY (1) | CY2450B1 (de) |
| DE (1) | DE69624927T2 (de) |
| GB (1) | GB9517758D0 (de) |
| WO (1) | WO1997007823A2 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9701127D0 (sv) | 1997-03-26 | 1997-03-26 | Karolinska Innovations Ab | Antigenic fusionprotein carrying GALal, 3GAL epitopes |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2569984B1 (fr) * | 1984-09-12 | 1987-08-14 | Anvar | Molecule synthetique contenant une pluralite d'epitopes distincts, procede pour son obtention et application a la production de polyvaccins |
| CA1339415C (en) * | 1989-08-24 | 1997-09-02 | Milton David Goldenberg | Detection and treatment of infections with immunoconjugates |
| US5401723A (en) * | 1992-12-02 | 1995-03-28 | Colgate-Palmolive Company | Glycoconjugate inhibition of Streptococcus pyrogenes adhesion |
| NZ290089A (en) * | 1994-07-27 | 1999-05-28 | Queensland Inst Med Res | Recombinant polyepitope cytotoxic t lymphocyte (ctl) vaccines |
-
1995
- 1995-08-31 GB GBGB9517758.0A patent/GB9517758D0/en active Pending
-
1996
- 1996-08-23 CA CA002229844A patent/CA2229844A1/en not_active Abandoned
- 1996-08-23 AU AU68293/96A patent/AU6829396A/en not_active Abandoned
- 1996-08-23 WO PCT/GB1996/002078 patent/WO1997007823A2/en active IP Right Grant
- 1996-08-23 CN CN96197293A patent/CN1198101A/zh active Pending
- 1996-08-23 JP JP9509983A patent/JPH11511455A/ja active Pending
- 1996-08-23 DE DE69624927T patent/DE69624927T2/de not_active Expired - Fee Related
- 1996-08-23 BR BR9609868A patent/BR9609868A/pt not_active Application Discontinuation
- 1996-08-23 EP EP96928566A patent/EP0847280B1/de not_active Expired - Lifetime
- 1996-08-23 AT AT96928566T patent/ATE228014T1/de not_active IP Right Cessation
-
2004
- 2004-04-28 CY CY0400032A patent/CY2450B1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0847280A2 (de) | 1998-06-17 |
| AU6829396A (en) | 1997-03-19 |
| JPH11511455A (ja) | 1999-10-05 |
| DE69624927T2 (de) | 2003-06-18 |
| CN1198101A (zh) | 1998-11-04 |
| WO1997007823A3 (en) | 1997-04-24 |
| EP0847280B1 (de) | 2002-11-20 |
| WO1997007823A2 (en) | 1997-03-06 |
| GB9517758D0 (en) | 1995-11-01 |
| DE69624927D1 (de) | 2003-01-02 |
| CA2229844A1 (en) | 1997-03-06 |
| BR9609868A (pt) | 1999-07-27 |
| ATE228014T1 (de) | 2002-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2270046A3 (de) | Verfahren und Zusammensetzungen zur Behandlung von mit Hämolyse assoziierten Krankheiten | |
| EP0441119A3 (en) | The use of l-arginine in the treatment of hypertension and other vascular disorders | |
| GR980300033T1 (en) | Compositions for the treatment of dermatological disorders and methods for their use | |
| NZ305822A (en) | Isolated presenilin genes and use in diagnosing Alzheimer's Disease | |
| EP1818343A3 (de) | Antikörper gegen humanes IL-12 | |
| LV12438A (en) | Metode of preventing and delyaing the onset of alzheimer's disease and composition thereof | |
| IT9022032A0 (it) | L-2'-desossiuridine e composizioni farmaceutiche che le contengono. | |
| BG102362A (en) | New derivatives of amino acids, their preparation and application | |
| ZA963586B (en) | Cosmetic compositions for the photoprotection of the skin and/or the hair based on a synergistic mixture of screening agents and their uses | |
| GR3023021T3 (en) | Synergising association having an antagonist effect on nk1 and nk2 receptors. | |
| GB2290018B (en) | Improved women's stocking and support | |
| PL338673A1 (en) | Application of fanquinone in treating alzheimer disease | |
| ZA962847B (en) | Treatment of traveller's diarrhea. | |
| MX9707642A (es) | Uso de 2-oxoindol-1-carboxamidas 3-sustituidas y sus sales de base farmaceuticamente aceptables para preparar composiciones para el tratamiento y prevencion de la enfermedad de alzheimer en mamiferos, incluyendo a humanos. | |
| GB9102816D0 (en) | Quenching and deodorizing compositions | |
| CY2450B1 (en) | Compositions and their uses. | |
| NZ323282A (en) | N,n'-bridged bisindolylmaleimides and their use to prepare n,n'-bridged bisindolylmaleimides | |
| ATE200624T1 (de) | Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis | |
| AU7755591A (en) | The use of synthetic metalloporphyrins in the treatment of hypertension and other vascular disorders | |
| HUP0000570A3 (en) | Use of 17 alpha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states | |
| AU6955294A (en) | Agents for the prevention and treatment of parkinson's disease | |
| LV5177A3 (lv) | Preparats "eridons" govju endometritu profilaksei un arstesanai | |
| CS245990A2 (en) | Chimaera immunogens against virus-caused diseases of flaviridae family and some bacteria | |
| HUP0000476A3 (en) | Use of 17 betha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states | |
| GB9503462D0 (en) | "Cleaning composition and its use" |